NeuroFore: Revolutionizing Early Parkinson’s Diagnosis with AI
Biotech Healthcare HealthTech Business Technology 2 Minutes
NeuroFore is a biotechnology startup based in St. Louis, Missouri, dedicated to revolutionizing the early diagnosis of Parkinson’s disease through artificial intelligence. By focusing on non-motor symptoms that precede traditional motor indicators, NeuroFore aims to enable earlier interventions, significantly improving patient outcomes and reducing healthcare costs.
Why They Stand Out
NeuroFore distinguishes itself by targeting Parkinson’s disease at its earliest stages through subtle non-motor symptoms such as sleep disturbances, olfactory loss, and mood changes symptoms that typically appear years before motor impairments. Their AI-driven diagnostic tool provides a non-invasive, accurate, and scalable solution, positioning NeuroFore as a pioneer in the field of neurological diagnostics.
Why Watch
Despite being relatively new, NeuroFore has achieved notable early milestones:
-
Hult Prize Semifinalist: Recognized among thousands of global teams for their innovative approach and social impact potential.
-
Skandalaris Venture Competition Semifinalist: Demonstrated strong early traction, validating their innovative approach and business potential.
These early successes highlight NeuroFore’s potential to significantly influence the future of neurodegenerative disease diagnosis.
Meet the Team
-
Hamasa Ebadi -Founder and CEO at NeuroFore, leveraging her background in neuroscience and bioethics to lead research on early Parkinson’s detection through AI-powered neurodiagnostics.
-
Joseph Hess: Business Strategy Team Lead at NeuroFore, combining expertise in business, computer science, and psychology to drive strategic growth.
-
Evan (Yuwen) Tan: Communications Lead, skilled in developing innovative outreach strategies to effectively engage diverse stakeholders.
WOWS Take
With significant whitespace in early-stage Parkinson’s diagnostics, NeuroFore’s innovative use of artificial intelligence to detect non-motor symptoms is set to become a game changer in neurodegenerative care. Their early recognition in prestigious competitions, paired with a visionary team and promising technological approach, make them one of the most exciting emerging biotech startups in the market today.
Want to be part of the future of AI-driven healthcare?
Check out NeuroFore's profile on WOWS Global’s Deal Flow platform and discover other groundbreaking startups shaping the future of medicine.
Related Posts
-
SEA Thailand Drone Platform Business Business Growth 5 Minutes
DroneEntry: Building the Full-Stack Enterprise Drone Platform for Southeast Asia
From an AIT-anchored hub in Thailand, DroneEntry unifies DJI Enterprise hardware, mission execution, and professional training for regulated, data-driven industries across SEA. Our spotlight breaks down differentiation, catalysts, and team plus what it means for investors and partners. Schedule a call with WOWS to dive deeper into the opportunity. -
Southeast Asia Healthcare hospitality tech SEA 4 Minutes
Huray: The Insurer-Integrated Chronic Care Platform to Watch
Huray builds payer-integrated digital programs for chronic diseases, combining connected devices, coaching, and clinician-backed pathways. With distribution through major insurers and a focus on measurable outcomes, the company is poised to scale across Asia’s rapidly evolving health-care landscape. -
SaaS HealthTech Southeast Asia SEA Fintech 6 Minutes
Founders Launchpad: Accelerating the Philippines’ next wave of startups
Founders Launchpad blends capital with hands-on operating support to turn early insights into traction. See why investors are watching this PH pre-seed powerhouse. -
SEA Biotech Corporate Venture deep-tech 3 Minutes
GC Ventures: Where Chemistry Meets Real-World Sustainability
GC Ventures, PTT Global Chemical’s corporate VC, backs founders at the intersection of chemistry and sustainability. With hubs in Bangkok and Cambridge (MA), they help deeptech teams scale advanced materials, clean & circular tech, industrial biotech, and digital industrial solutions from lab to plant across Southeast Asia. -
AI Sales Automation SME Business 2 Minutes
SalesHero.io: AI-Powered LinkedIn Sales Automation for SMEs
SalesHero.io is revolutionizing LinkedIn prospecting through AI-powered personalized automation, enabling SMEs to streamline sales processes and boost conversions effortlessly. -
Impact Investing Fintech Healthcare Greentech SEA 4 Minutes
Ficus Capital: Building Ethical and Impact-Driven Ventures Across Southeast Asia
Ficus Capital is Southeast Asia’s first ESG-Islamic VC, investing in early-stage startups that align profit with principle. Backed by MAVCAP and MGTC, Ficus supports high-impact ventures across greentech, fintech, healthtech, and more, proving that sustainable growth and Shariah compliance can go hand in hand.